Hip Replacement Market
                     Hip Replacement Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Hip replacement is a surgical procedure in which the hip joint is replaced by an 
artificial prosthetic implant.  The procedure is called hip arthroplasty. The 
surgery is generally conducted to relieve joint pain (arthritis) or for the 
treatment of physical hip joint damage and hip fractures. Hip replacement surgery 
can be performed as a total replacement or a hemi (half) replacement.
The global hip replacement market is estimated to account for US$ 10,311.3 Mn in 
terms of value by the end of 2027.
Browse Summary of the Research Report- 
https://www.coherentmarketinsights.com/market-insight/hip-replacement-market-3642
Increasing prevalence of musculoskeletal disorders is expected to boost growth of 
the global hip replacement market over the forecast period. For instance, according
to the study, ‘Osteoarthritis year in review 2019: epidemiology and therapy’, 
published in the journal Osteoarthritis and Cartilage in January 2020, the median 
proportion of years lived with disability due to musculoskeletal disorders 
increased from 11.8% in 2000 to 13.5% (9.6–16.6) in 2015.
Moreover, increasing number of knee arthroplasty procedures is also expected to aid
in growth of the market. For instance, in 2018, the American Academy of Orthopedic 
Surgeons (AAOS) and the American Joint Replacement Registry (AJRR) recorded over 1 
million patients and over 1.4 million hip and knee arthroplasty procedures.
North America region held dominant position in the global hip replacement market in
2014, accounting for 45.5% share in terms of value, followed by Europe.Stringent 
regulator scenario regarding marketing of hip replacement is expected to hinder 
growth of the market. For instance, from May 2016, the U.S. FDA mandated that all 
manufacturers of metal-on-metal total hip implants are required to stop marketing 
their devices and submit premarket approvals for approval before marketing the 
devices.
Moreover, high cost of hip implant products and surgeries is expected to hamper 
growth of the market. For instance, hip replacement surgery costs around US$ 20,000
to US$ 60,000 in the U.S.
Global Hip Replacement Market: Opportunities Increasing geriatric population is 
expected to offer lucrative growth opportunities for players in the global hip 
replacement market. For instance, according to the World Health Organization, 
geriatric population is expected to reach 2 billion by 2050, up from 900 million in
2015.
Moreover, increasing number of accidents is also expected to aid in growth of the 
market. For instance, according to 2018 Fatal Motor Vehicle Crashes: Overview by 
National Highway Traffic Safety Administration, a U.S. federal agency, 10,511 
deaths were registered in the U.S. in 2018.Total Hip Replacement Implant segment in
the global hip replacement market was valued at US$ 4,179.1 Mn in 2019and is 
expected to reach US$ 6,112.4 Mn by 2027 at a CAGR of 4.9% during the forecast 
period.
The U.S. FDA has not approved any metal-on-metal total hip replacement devices for 
use in the US. There are two FDA-approved metal-on-metal hip resurfacing devices 
available, one of which was developed by Smith & Nephew.In the U.S., government 
bodies are focused reducing expenditures of common inpatient surgeries for Medicare
beneficiaries. For instance, in February 2020, the Centers for Medicare & Medicaid 
Services issued a proposed rule in the Federal Register proposing a three-year 
extension and changes to the episode definition and pricing in the Comprehensive 
Care for Joint Replacement Model.
According to the U.S. FDA most, but not all, prosthetic components and controls are
classified as class I. Almost all class I devices are exempt from premarket 
notification by FDA, but as such are subject to regulation by the U.S. FDA, Center 
for Devices and Radiological Health (CDRH).According to 21 CFR Part (Parts 800-
1299) of the FDA’s Product Classification Listings, all prosthetic devices must 
comply with Federal regulations through FDA/CDRH processes. (Parts 890.3420 and 
890.3025), the FDAs product classification listings, external limb prosthestic 
components, and accessories are defined as physical medicine devices and are 
generally considered class I devices.
Major players operating in the global hip replacement market include, Depuy Synthes
(Johnson & Johnson), Microport Scientific Corporation, Zimmer Biomet, Exactech 
Inc., DJO Global Inc., Stryker Corporation, B. Braun Melsungen, and Smith & Nephew.
Major players in the market are focused on expanding their service portfolio. For 
instance, in February 2020, Smith & Nephew announced 'Positive Connections', a 
turnkey service to support healthcare providers that are focused on offering 
increased access for orthopedic cases to Ambulatory Surgery Centers (ASCs) and 
other outpatient settings.
Players in the market are also focused on launching Artificial Intelligence (AI)-
based products. For instance, in December 2019, RSIP Vision, an AI, computer 
vision, and image processing technology company, launched a new AI-based total hip 
replacement solution that provides a precise, automated 3D structure of the 
patients' hip for effective surgery.
Request A Sample Copy - https://www.coherentmarketinsights.com/insight/request-
sample/3642
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
*****************************************************************************